Humanized anti-CD79b antibodies and immunoconjugates and methods of use
US9845355B2 · kind B2 · utility
19Cited by
9References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2008 |
| Grant date | Dec 19, 2017 |
| Priority date | — |
| Expiry date | Oct 26, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to anti-CD79b antibodies with specific hypervariable region sequences in the heavy and light chain variable domains as enumerated in the SEQ ID NOs described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.